Vir Biotechnology Inc.
VIR:NASDAQ
Vir Biotechnology is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
Streetwise Company Fact Sheet
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
